Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Martin J Carroll


  • Director at Mallinckrodt Plc (MNK), 2019-05-17
  • Director at Catalent Inc. (CTLT), 2018-08-24
  • Director at Therapeuticsmd Inc. (TXMD), 2018-07-05
  • Director at Inotek Pharmaceuticals Corp (ITEK), 2017-06-21
  • Director at Durata Therapeutics Inc. (DRTX), 2014-11-18
  • Director at Vivus Inc (VVUS), 2013-08-16
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MNK $20.42 5,000 Director 23,423 2017-11-09 Filing
ITEK $9.03 10,000 Director 10,000 2016-05-13 Filing
TXMD $6.11 10,000 Director 10,000 2015-05-08 Filing
MNK $69.24 2,000 Director 9,209 2014-08-12 Filing
MNK $51.27 2,000 Director 5,034 2013-11-26 Filing